Literature DB >> 9924580

Electroencephalographic photosensitivity among Zimbabwean youths.

J B Familusi1, B Adamolekun, B A Olayinka, D Muzengi, L F Levy.   

Abstract

To clarify the factors associated with electroencephalographic (EEG) photosensitivity, the records of patients who had EEG examinations in the city of Harare, Zimbabwe between 1968 and 1996 were studied. EEG photosensitivity was confirmed in 107 of a total of 9082 youths (aged 0-25 years), giving an overall photosensitivity prevalence of 1.17% in the study population. Photosensitivity occurred more frequently in females than in males, and the peak age period for its occurrence was during adolescence. A significantly higher prevalence of photosensitivity was recorded among Whites and Asians than among Blacks, while the Coloured population had an intermediate prevalence. The monthly and seasonal incidence of photosensitivity in the present study showed no correlation with the prevailing mean monthly or seasonal temperatures, sunshine duration and sunlight intensity in Harare during the period covered by the study. These findings indicate that sunshine-related factors do not play a dominant role in the occurrence of photosensitivity, thereby negating previous opinions which attributed the relative rarity of photosensitivity in black Africans to high levels of exposure to sunshine in tropical Africa. Our findings therefore corroborate the view that photosensitivity depends primarily on genetic rather than environmental factors.

Entities:  

Mesh:

Year:  1998        PMID: 9924580     DOI: 10.1080/02724936.1998.11747958

Source DB:  PubMed          Journal:  Ann Trop Paediatr        ISSN: 0272-4936


  1 in total

1.  A retrospective observational study of EEG findings and antiepileptic drug use among children referred for EEG to Zambia's University Teaching Hospital.

Authors:  Ornella Ciccone; Chishala Chabala; Owen Tembo; Manoj Mathew; Alice K Grollnek; Archana A Patel; Gretchen L Birbeck
Journal:  Epilepsia Open       Date:  2018-10-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.